[HTML][HTML] Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

A Armulik, G Genové, C Betsholtz - Developmental cell, 2011 - cell.com
Pericytes, the mural cells of blood microvessels, have recently come into focus as regulators
of vascular morphogenesis and function during development, cardiovascular homeostasis …

Canonical and non-canonical Notch ligands

B D'Souza, L Meloty-Kapella, G Weinmaster - Current topics in …, 2010 - Elsevier
Notch signaling induced by canonical Notch ligands is critical for normal embryonic
development and tissue homeostasis through the regulation of a variety of cell fate decisions …

Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency

WC Yen, MM Fischer, F Axelrod, C Bond, J Cain… - Clinical cancer …, 2015 - AACR
Abstract Purpose: The Notch pathway plays an important role in both stem cell biology and
cancer. Dysregulation of Notch signaling has been reported in several human tumor types …

The many facets of Notch ligands

B D'souza, A Miyamoto, G Weinmaster - Oncogene, 2008 - nature.com
The Notch signaling pathway regulates a diverse array of cell types and cellular processes
and is tightly regulated by ligand binding. Both canonical and noncanonical Notch ligands …

The notch ligand JAGGED1 as a target for anti-tumor therapy

D Li, M Masiero, AH Banham, AL Harris - Frontiers in oncology, 2014 - frontiersin.org
The Notch pathway is increasingly attracting attention as a source of therapeutic targets for
cancer. Ligand-induced Notch signaling has been implicated in various aspects of cancer …

NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1

H Liu, S Kennard, B Lilly - Circulation research, 2009 - Am Heart Assoc
Endothelial cells and mural cells (smooth muscle cells, pericytes, or fibroblasts) are known
to communicate with one another. Their interactions not only serve to support fully functional …

[HTML][HTML] Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy

B Yetkin-Arik, AW Kastelein, I Klaassen… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Angiogenesis is required in cancer, including gynecological cancers, for the growth of
primary tumors and secondary metastases. Development of anti-angiogenesis therapy in …

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

HJ Broxterman, KJ Gotink, HMW Verheul - Drug resistance updates, 2009 - Elsevier
Multiple molecular, cellular, micro-environmental and systemic causes of anticancer drug
resistance have been identified during the last 25 years. At the same time, genome-wide …

Molecular mechanisms underlying therapeutic potential of pericytes

CR Harrell, B Simovic Markovic, C Fellabaum… - Journal of biomedical …, 2018 - Springer
Background Pericytes are multipotent cells present in every vascularized tissue in the body.
Despite the fact that they are well-known for more than a century, pericytes are still …

Mechanisms of resistance to antiangiogenesis therapy

F Azam, S Mehta, AL Harris - European journal of cancer, 2010 - Elsevier
Angiogenesis, the formation of new blood vessels from existing vasculature, plays an
essential role in tumour growth, invasion and metastasis. Vascular endothelial growth factor …